Eman T. Al-Antary

Dr. Eman T. Al-Antary

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2023 in Vaccines
Verified
Journal Article
Open access
PDF file
ACAlexander Ciurej
Alexander Ciurej
ELElizabeth Lewis
Elizabeth Lewis
AGAvanti Gupte
Avanti Gupte
EAEman T. Al-Antary
Eman T. Al-Antary
Immune checkpoint inhibitors (ICIs) are a relatively new class of immunotherapy which bolsters the host immune system by “turning off the brakes” of effector cells (e.g., CTLA-4, PD-1, PD-L1). Although their success in treating adult malignancy is well documented, their utility in pediatric cancer has not yet been shown to be as fruitful. We review ICIs, their use in pediatric malignancies, and active pediatric clinical trials, exemplifying some of adult efforts that could be related to pediatric future trials and complications of ICI therapy. Through our review, we propose the consideration of ICI as standard therapy in lymphoma and various solid tumor types, especially in relapsed or refractory (R/R) disease. However, further studies are needed to demonstrate ICI effectiveness in pediatric leukemia.

24 October 2014 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
AHAyad Ahmed Hussein
Ayad Ahmed Hussein
EAEman T. Al-Antary
Eman T. Al-Antary
RNRula Najjar
Rula Najjar
DADua'A S. Al‐Hamdan
Dua'A S. Al‐Hamdan
AAAbdulhadi Al‐Zaben
Abdulhadi Al‐Zaben
HFHaydar Frangoul
Haydar Frangoul

15 March 2023 in Vaccines
Verified
Journal Article
Open access
PDF file
GKGhadir K. Katato
Ghadir K. Katato
PSPrasiksha Sitaula
Prasiksha Sitaula
AGAvanti Gupte
Avanti Gupte
EAEman T. Al-Antary
Eman T. Al-Antary
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic affected the pediatric oncology population globally. Over the course of 2 years, increasing reports have been made to better understand this entity and its pathologic complications on these patients. The pandemic has allowed healthcare providers, hospital systems, and leading oncologic societies to quickly adapt and formulate new guidelines for the effective understanding, management, and treatment of patients with pediatric malignancy.

28 December 2021 in Journal of Pediatric Hematology/Oncology
Verified
Journal Article
Closed access
EAEman T. Al-Antary
Eman T. Al-Antary
RARewa Arar
Rewa Arar
YPYogindra Persaud
Yogindra Persaud
BFBasil Fathalla
Basil Fathalla
MRMadhvi Rajpurkar
Madhvi Rajpurkar
KBKanta Bhambhani
Kanta Bhambhani
The understanding of coronavirus disease 2019 (COVID-19) immune dysregulation is evolving. Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease with alternations in both innate and adaptive immunity, probably caused by a complex interplay of genetics and environmental exposure with various triggers. A rare hematological complication of SLE as well as recently reported in an adult with COVID-19 is thrombotic thrombocytopenic purpura. We report a pediatric case with features suggestive of the multisystem inflammatory syndrome in children with coronary artery ectasia, thrombotic thrombocytopenic purpura, and new-onset SLE.

13 August 2021 in Journal of Pediatric Hematology/Oncology
Verified
Journal Article
Closed access
EAEman T. Al-Antary
Eman T. Al-Antary
AGAvanti Gupte
Avanti Gupte
JPJanet Poulik
Janet Poulik
JKJustin Klein
Justin Klein
HGHamza S. Gorsi
Hamza S. Gorsi
Juvenile xanthogranuloma (JXG) is a rare, non–Langerhans cell histiocytosis. It is usually a benign and self-limiting condition. The most common sites are skin and soft tissue. Pancreatic involvement is extremely rare. We present an unusual case of a 13-month-old female child with JXG of the pancreas and elevated cancer antigen 19-9. JXG should always be considered as a differential diagnosis for pediatric patients presenting with a pancreatic mass, solid and/or cystic in nature. Therefore, avoiding unnecessary invasive diagnostic procedures.

1 April 2019 in Journal of Pediatric Hematology/Oncology
Verified
Journal Article
Closed access
EAEman T. Al-Antary
Eman T. Al-Antary
RJRohith Jesudas
Rohith Jesudas
AGAmy George
Amy George
JPJanet Poulik
Janet Poulik
SSSüreyya Savaşan
Süreyya Savaşan
Syncytial variant of nodular sclerosis (SV-NS) classical Hodgkin lymphoma (cHL) with its histologic features and clinical presentation is uncommon in adults and extremely rare in children. Here, we report a female teenager presenting with long-standing B symptoms, prominent soft tissue and bone involvement mimicking sarcoma and significant nodal disease who is diagnosed with advanced SV-NS cHL. Rare Reed-Sternberg-like cells displaying neutrophil and erythrocyte emperipolesis were seen on bone marrow aspiration slides. Despite initial complete response to chemotherapy and radiotherapy, the patient experienced early relapse suggestive of high-risk biology. This variant may constitute a unique entity.